All Online

301 - 312 of 357 results

Refine

Active filters

Man vaping in the street
0.25 CME CREDIT

Bad News for E-Cigarette Users—Possible Link Between E-Cigarettes And ED - Frankly Speaking EP 267

Guest: Susan Feeney, DNP, FNP-BC, NP-CMusic Credit: Richard Onorato

0.25 CME

The clinical literature is filled with new and evolving evidence on the use of e-cigarettes and potential harms. The question of their use as a harm reduction strategy is a hotly debated topic—pitting traditional combustible tobacco with its well-known effect on morbidity and mortality against electronic nicotine delivery systems (ENDS), which although not harmless, are considered less harmful than smoked cigarettes. Recent evidence is emerging on the potential cardiovascular risks posed by newer generations of ENDS with far greater delivery of nicotine. Join us while we discuss the findings from a recent study that examines ENDS use and associated increase rates of erectile dysfunction (ED) and how this information may impact your practice.


Gabapentinoid Drugs Off-Label Use: Stay in Your Lane! - Frankly Speaking EP 127

Guest: Jill Terrien PhD, ANP-BC Music Credit: Richard Onorato

Join us as we discuss the increased off-label use of gabapentinoids most likely in response to the treatment of pain.


Reading to young children is a well-established activity that can impact neuro-cognitive and emotional development in children. Since many parents use E-readers and other digital platforms to read to their kids, in this episode we will explore whether there is a difference or benefit to using a particular type of book. Join us as we discuss the recent findings on parent-toddler interactions when reading from a print book versus an E-reader.


0.25 CME CREDIT

Fever Free: Acetaminophen or Ibuprofen? - Frankly Speaking EP 266

Guest: Jillian Joseph, MSPAS, PA-CMusic Credit: Richard Onorato

0.25 CME

‘Tis the season for pediatric fevers! Join us to review a recent meta-analysis looking at 18 studies with patients younger than 2 years old who received acetaminophen or ibuprofen for fever or pain to determine if one medication should be recommended first, before the other. After this session, you’ll be able to confidently advise parents of young children on how best to manage fever and/or pain at home with over-the-counter medications.


Barriers to Physical Activity: Women's Breast Size - Frankly Speaking EP 125

Guest: Jill Terrien PhD, ANP-BCMusic Credit: Richard Onorato

Join us as we discuss barriers to physical activity and how providers can help to address these issues, particularly in women with large breast size.


0.25 CME CREDIT

Fluvoxamine as a Treatment for COVID-19 - Frankly Speaking EP 265

Guest: Alan M. Ehrlich, MD, FAAFPMusic Credit: Richard Onorato

0.25 CME

Most cases of COVID-19 will resolve without interventions, but some patients are at high risk for complications. Several treatment options for high-risk patients are now available to help prevent the need for hospitalization. Join us to review a recent large, randomized trial evaluating fluvoxamine as a treatment for high-risk patients who were diagnosed with COVID-19.


0.25 CME CREDIT

COVID-19 and Children - Frankly Speaking EP 264

Guest: Jillian Joseph, MSPAS, PA-CMusic Credit: Richard Onorato

0.25 CME

Get answers to your questions on COVID-19 infection in children. Listen to this podcast to review outcomes and potential risk factors associated with acute COVID-19 infection in this population. Finally, learn the status of immunizations for children younger than 5 years of age.


Contraceptive Education: Educate Your Patients While They Wait - Frankly Speaking EP 123

Guest: Jill Terrien PhD, ANP-BC Music Credit: Richard Onorato

Join us as we discuss decision aids used to assess contraceptive knowledge and intentions that can be easily incorporated in primary care practice.


0.25 CME CREDIT

Oral Anti-COVID 19 Medications – a Game Changer? - Frankly Speaking EP 263

Guest: Robert A. Baldor, MD, FAAFPMusic Credit: Richard Onorato

0.25 CME

The FDA’s recent emergency use authorization (EUA) for oral agents to treat COVID-19 means that primary care providers (PCPs) will be on the frontline of treating patients with COVID-19. Therefore, PCPs must understand who is eligible for such treatments and how to prescribe them. We will discuss the results of the recent FDA EUA for Pfizer’s Paxlovid and Merck’s molnupiravir antiviral agents and give you the information you need to confidently prescribe them.


Fear Not the Fungus Treatment - Frankly Speaking EP 122

Guest: Susan Feeney, DNP, FNP Music Credit: Richard Onorato

Since their arrival, oral anti-fungal agents have been thought to induce liver disease. Often, these medications are avoided or used with caution and frequent laboratory testing. Join us in a discussion of a recent study that builds on previous work showing the risk of using these agents is extremely small.


According to the latest data, 1 in 7 US women experience perinatal depression, described as depression occurring during pregnancy and up to one year after childbirth. There is compelling evidence that perinatal depression can have short and long-term effects on both women and their children. The USPSTF has published new recommendations encouraging clinicians to screen pregnant and postpartum persons for depression and provide those who are at increased risk of perinatal depression with counseling interventions. (Grade B recommendation).


In a recent study of postmenopausal women in the WHI Observational Study who consumed > 2 ASB per day, there appeared to be an association between increased intake of ASB with increased risk of ischemic stroke, CVD, and all cause mortality. Join us as we discuss these findings, what it adds to our knowledge about ASB, and potential strategies to apply this new evidence into your practice.